Clinical Trials
291 trialsSANGUINE
JaxBio Ltd
INTHEMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
SYS01
University Hospital Tuebingen
PUMA
Institute of Cancer Research, United Kingdom
INO-FIRST
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
Gruppo Italiano Malattie EMatologiche dell'Adulto
ORAZ-351
Centre Hospitalier Universitaire de Nice
ACC Platform
Fondazione del Piemonte per l'Oncologia
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology
European Institute of Oncology
Unravelling the Role of KCTD Protein Family in the Clinical Management of Childhood Acute Lymphoblastic Leukemias
IRCCS SYNLAB SDN
EXALT-2
Medical University of Vienna
BCR-ABL1
Siriraj Hospital
Is Ibrutinib-related Atrial Fibrillation Dose Dependent
University Hospital, Caen
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
SKETCh
The Christie NHS Foundation Trust
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
Sohag University
Preliminary Assessment of [18F]BL40 in PET/CT Scans
British Columbia Cancer Agency
MPL - NPM
Centre Hospitalier Universitaire de NÄ«mes
TIRE
Imperial College Healthcare NHS Trust
COVIDVAC OH
Assistance Publique - Hôpitaux de Paris
Turkish Cultural Adaptation, Validity and Reliability of the "Gait Outcomes Assessment List"
Istanbul University - Cerrahpasa
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
University of British Columbia
Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients
Peking Union Medical College Hospital
The Role of NK Cells to Detect Blood Infection in ALL.
Assiut University
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
University of British Columbia
Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial
Sutter Health
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Gruppo Italiano Malattie EMatologiche dell'Adulto
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Technical University of Munich
IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation
University Hospital, Caen
Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI
Assiut University
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Central Hospital, Nancy, France
MASSAYA
Centre Leon Berard
Elattar
Mansoura University
Immune Reconstitution After Allo-HSCT and Blinatumomab
Sichuan University
Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies
The First Affiliated Hospital of Soochow University
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
Alliance for Clinical Trials in Oncology
The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation
Peking University People's Hospital
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
TIPHI
Centre Hospitalier Universitaire de NÄ«mes
CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
Diabeter Nederland BV
Oral Complications in Hematological Malignancies
Assiut University
PeKiT
Imagine Institute
H19 in Acute Lymphoblastic Leukemia.
Assiut University
FDG-PETAML
First Affiliated Hospital of Jinan University
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.
University of Milano Bicocca
Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia
Rigshospitalet, Denmark
The Association of Gut Microbiota With COVID 19 Infection in Children
Hallym University Kangnam Sacred Heart Hospital
Ponderosa
University of Jena
Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation
The Children's Hospital of Zhejiang University School of Medicine